Edwards Lifesciences Net Profit Margin 2010-2024 | EW

Current and historical net profit margin for Edwards Lifesciences (EW) from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. Edwards Lifesciences net profit margin for the three months ending March 31, 2024 was .
Edwards Lifesciences Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-03-31 $6.14B $1.41B 23.02%
2023-12-31 $6.01B $1.40B 23.36%
2023-09-30 $5.82B $1.43B 24.59%
2023-06-30 $5.66B $1.39B 24.57%
2023-03-31 $5.50B $1.49B 27.07%
2022-12-31 $5.38B $1.52B 28.28%
2022-09-30 $5.36B $1.46B 27.20%
2022-06-30 $5.36B $1.46B 27.17%
2022-03-31 $5.36B $1.54B 28.73%
2021-12-31 $5.23B $1.50B 28.72%
2021-09-30 $5.10B $1.48B 29.01%
2021-06-30 $4.93B $1.46B 29.70%
2021-03-31 $4.48B $0.85B 19.02%
2020-12-31 $4.39B $0.82B 18.78%
2020-09-30 $4.37B $0.79B 18.17%
2020-06-30 $4.32B $0.74B 17.21%
2020-03-31 $4.48B $1.11B 24.71%
2019-12-31 $4.35B $1.05B 24.08%
2019-09-30 $4.15B $0.77B 18.64%
2019-06-30 $3.97B $0.73B 18.28%
2019-03-31 $3.82B $0.77B 20.04%
2018-12-31 $3.72B $0.72B 19.41%
2018-09-30 $3.64B $0.71B 19.61%
2018-06-30 $3.55B $0.66B 18.51%
2018-03-31 $3.45B $0.56B 16.24%
2017-12-31 $3.44B $0.58B 16.96%
2017-09-30 $3.32B $0.75B 22.47%
2017-06-30 $3.23B $0.72B 22.15%
2017-03-31 $3.15B $0.66B 20.86%
2016-12-31 $2.96B $0.57B 19.24%
2016-09-30 $2.87B $0.55B 19.26%
2016-06-30 $2.74B $0.53B 19.29%
2016-03-31 $2.60B $0.52B 19.80%
2015-12-31 $2.49B $0.50B 19.85%
2015-09-30 $2.44B $0.46B 18.97%
2015-06-30 $2.43B $0.44B 18.09%
2015-03-31 $2.39B $0.87B 36.57%
2014-12-31 $2.32B $0.81B 34.93%
2014-09-30 $2.24B $0.78B 34.69%
2014-06-30 $2.13B $0.76B 35.65%
2014-03-31 $2.07B $0.31B 14.73%
2013-12-31 $2.05B $0.39B 19.01%
2013-09-30 $2.02B $0.40B 19.95%
2013-06-30 $1.97B $0.40B 20.03%
2013-03-31 $1.94B $0.37B 19.10%
2012-12-31 $1.90B $0.29B 15.32%
2012-09-30 $1.82B $0.27B 14.57%
2012-06-30 $1.78B $0.25B 13.90%
2012-03-31 $1.73B $0.24B 13.73%
2011-12-31 $1.68B $0.24B 14.12%
2011-09-30 $1.64B $0.24B 14.56%
2011-06-30 $1.58B $0.24B 14.90%
2011-03-31 $1.51B $0.24B 15.55%
2010-12-31 $1.45B $0.22B 15.13%
2010-09-30 $1.40B $0.20B 14.41%
2010-06-30 $1.38B $0.23B 16.53%
2010-03-31 $1.35B $0.22B 16.15%
2009-12-31 $1.32B $0.23B 17.46%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $52.601B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $218.361B 26.46
Intuitive Surgical (ISRG) United States $151.024B 90.98
DexCom (DXCM) United States $46.111B 69.85
Alcon (ALC) Switzerland $44.714B 32.04
IDEXX Laboratories (IDXX) United States $41.624B 48.79
IQVIA Holdings (IQV) United States $38.763B 22.49
STERIS (STE) Ireland $21.579B 25.21
SONOVA HOLDING (SONVY) Switzerland $18.556B 0.00
Waters (WAT) United States $17.496B 25.71
Hologic (HOLX) United States $16.754B 18.74
Fresenius Medical Care AG KGaA (FMS) Germany $12.100B 14.12
Sysmex ADR (SSMXY) Japan $9.900B 31.05
Teleflex (TFX) United States $9.811B 15.27
Globus Medical (GMED) United States $8.882B 26.04
Penumbra (PEN) United States $7.279B 82.72
Masimo (MASI) United States $7.203B 41.49
Glaukos (GKOS) United States $5.671B 0.00
TransMedics (TMDX) United States $4.677B 443.78
Integer Holdings (ITGR) United States $3.897B 23.55
PROCEPT BioRobotics (PRCT) United States $3.248B 0.00
Tandem Diabetes Care (TNDM) United States $2.928B 0.00
LivaNova (LIVN) United Kingdom $2.853B 16.94
Inari Medical (NARI) United States $2.634B 0.00
Nihon Kohden (NHNKY) Japan $2.601B 13.78
Elekta AB (EKTAY) Sweden $2.365B 18.13
Integra LifeSciences Holdings (IART) United States $2.305B 10.05
RxSight (RXST) United States $2.141B 0.00
Veracyte (VCYT) United States $1.603B 0.00
Alphatec Holdings (ATEC) United States $1.491B 0.00
Artivion (AORT) United States $0.964B 92.48
AVANOS MEDICAL, INC (AVNS) United States $0.883B 17.18
OPKO Health (OPK) United States $0.871B 0.00
Silk Road Medical (SILK) United States $0.844B 0.00
OrthoPediatrics (KIDS) United States $0.698B 0.00
Pulse Biosciences (PLSE) United States $0.664B 0.00
IRadimed (IRMD) United States $0.548B 30.67
SiBone (SIBN) United States $0.522B 0.00
Paragon 28 (FNA) United States $0.510B 0.00
Mesa Laboratories (MLAB) United States $0.494B 14.66
Pacific Biosciences Of California (PACB) United States $0.479B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.465B 0.00
Treace Medical Concepts (TMCI) United States $0.375B 0.00
AxoGen (AXGN) United States $0.334B 0.00
Nevro (NVRO) United States $0.332B 0.00
Sight Sciences (SGHT) United States $0.326B 0.00
Tactile Systems Technology (TCMD) United States $0.280B 9.58
Semler Scientific (SMLR) United States $0.271B 13.73
AngioDynamics (ANGO) United States $0.246B 0.00
CVRx (CVRX) United States $0.220B 0.00
Delcath Systems (DCTH) United States $0.212B 0.00
908 Devices (MASS) United States $0.200B 0.00
EDAP TMS S.A (EDAP) France $0.200B 0.00
NeuroPace (NPCE) United States $0.186B 0.00
Inogen (INGN) United States $0.172B 0.00
Accuray (ARAY) United States $0.172B 0.00
Alpha Tau Medical (DRTS) Israel $0.160B 0.00
Atossa Genetics (ATOS) United States $0.151B 0.00
ClearPoint Neuro (CLPT) United States $0.148B 0.00
Yubo Biotech (YBGJ) China $0.123B 0.00
Spectral Diagnostics (EDTXF) Canada $0.101B 0.00
KORU Medical Systems (KRMD) United States $0.098B 0.00
Sensus Healthcare (SRTS) United States $0.087B 18.28
Monogram Orthopaedics (MGRM) United States $0.065B 0.00
EnVVeno Medical (NVNO) United States $0.064B 0.00
InspireMD (NSPR) Israel $0.063B 0.00
Hyperfine (HYPR) United States $0.063B 0.00
Neuronetics (STIM) United States $0.061B 0.00
SEP Acquisition (SEPA) United States $0.055B 0.00
LENSAR (LNSR) United States $0.053B 0.00
Envoy Medical (COCH) United States $0.051B 0.00
T2 Biosystems (TTOO) United States $0.045B 0.00
Vicarious Surgical (RBOT) United States $0.040B 0.00
Lucid Diagnostics (LUCD) United States $0.039B 0.00
ReWalk Robotics (LFWD) Israel $0.039B 0.00
Precision Optics (POCI) United States $0.037B 0.00
DarioHealth (DRIO) United States $0.035B 0.00
Rapid Micro Biosystems (RPID) United States $0.033B 0.00
Accelerate Diagnostics (AXDX) United States $0.030B 0.00
Spectral AI (MDAI) United States $0.028B 0.00
Autonomix Medical (AMIX) United States $0.028B 0.00
Pixie Dust Technologies (PXDT) Japan $0.026B 0.00
Aspira Women's Health (AWH) United States $0.025B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.024B 0.00
Ekso Bionics Holdings (EKSO) United States $0.019B 0.00
QT Imaging Holdings (QTI) United States $0.016B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
NexGel (NXGL) United States $0.014B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
PAVmed (PAVM) United States $0.010B 0.00
Venus Concept (VERO) Canada $0.006B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
ENDRA Life Sciences (NDRA) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00